84 related articles for article (PubMed ID: 18373546)
1. Exploring QSARs for binding affinity of azoles with CYP2B and CYP3A enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Chem Biol Drug Des; 2008 May; 71(5):464-473. PubMed ID: 18373546
[TBL] [Abstract][Full Text] [Related]
2. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
[TBL] [Abstract][Full Text] [Related]
3. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
4. Toward basic understanding of the partition coefficient log P and its application in QSAR.
Chuman H
SAR QSAR Environ Res; 2008; 19(1-2):71-9. PubMed ID: 18311635
[TBL] [Abstract][Full Text] [Related]
5. Exploring QSAR for CYP11B2 binding affinity and CYP11B2/CYP11B1 selectivity of diverse functional compounds using GFA and G/PLS techniques.
Roy PP; Roy K
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):354-69. PubMed ID: 20030574
[TBL] [Abstract][Full Text] [Related]
6. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
Bhattacharya P; Leonard JT; Roy K
J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
[TBL] [Abstract][Full Text] [Related]
7. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Leonard JT; Roy K
Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
[TBL] [Abstract][Full Text] [Related]
8. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling of toxicity of diverse organic chemicals to Daphnia magna using 2D and 3D descriptors.
Kar S; Roy K
J Hazard Mater; 2010 May; 177(1-3):344-51. PubMed ID: 20045248
[TBL] [Abstract][Full Text] [Related]
10. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.
Lewis DF; Ito Y; Lake BG
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):679-84. PubMed ID: 20100069
[TBL] [Abstract][Full Text] [Related]
12. QSTR with extended topochemical atom (ETA) indices. VI. Acute toxicity of benzene derivatives to tadpoles (Rana japonica).
Roy K; Ghosh G
J Mol Model; 2006 Feb; 12(3):306-16. PubMed ID: 16249936
[TBL] [Abstract][Full Text] [Related]
13. Environmental toxicological fate prediction of diverse organic chemicals based on steady-state compartmental chemical mass ratio using quantitative structure-fate relationship (QSFR) models.
Pramanik S; Roy K
Chemosphere; 2013 Jul; 92(5):600-7. PubMed ID: 23642702
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
15. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
Roy K; Leonard JT
J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
[TBL] [Abstract][Full Text] [Related]
16. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
Mitra I; Roy K; Saha A
J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
[TBL] [Abstract][Full Text] [Related]
17. Novel semi-automated methodology for developing highly predictive QSAR models: application for development of QSAR models for insect repellent amides.
Bhonsle JB; Bhattacharjee AK; Gupta RK
J Mol Model; 2007 Jan; 13(1):179-208. PubMed ID: 17048015
[TBL] [Abstract][Full Text] [Related]
18. Comparative QSAR modeling of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas.
Thomas Leonard J; Roy K
Bioorg Med Chem Lett; 2006 Sep; 16(17):4467-74. PubMed ID: 16806923
[TBL] [Abstract][Full Text] [Related]
19. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
Roy PP; Roy K
Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]